{"transactions":[{"id":940540,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-14T02:14:07.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on January 9, 2027, and thereafter 1/36th of the remaining shares will vest on the last day of each following month for a period of 36 months, subject to the Reporting Person's continued employment."}],"balance_after":250000,"derivative":{"exercise_price":13.3,"expiration_date":"2036-01-09","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001841785-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/34956/000184178526000001/primary_doc.xml","form_type":"4"}},{"id":975387,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-10T23:48:57.000Z","date":"2025-12-09","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":10.2168,"value":25542.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $9.70 to $10.45. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":5266,"source":{"system":"sec-edgar","filing":"0001841785-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/34956/000184178525000004/primary_doc.xml","form_type":"4"}},{"id":975386,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-10T23:48:57.000Z","date":"2025-12-08","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":10.1002,"value":25250.5,"ownership":{"direct":false,"nature":"By Stuart Rich Revocable Trust DTD 11/18/1996"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $9.76 to $10.42. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is trustee of the Stuart Rich Revocable Trust DTD 11/18/1996 and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001841785-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34956/000184178525000004/primary_doc.xml","form_type":"4"}},{"id":979810,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-05T22:46:32.000Z","date":"2025-12-04","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":9.1992,"value":22998.0,"ownership":{"direct":false,"nature":"By Stuart Rich Revocable Trust DTD 11/18/1996"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $9.00 to $9.46. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is trustee of the Stuart Rich Revocable Trust DTD 11/18/1996 and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001841785-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/34956/000184178525000003/primary_doc.xml","form_type":"4"}},{"id":979809,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-05T22:46:32.000Z","date":"2025-12-03","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":9.0786,"value":13617.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $8.88 to $9.22. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":2766,"source":{"system":"sec-edgar","filing":"0001841785-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/34956/000184178525000003/primary_doc.xml","form_type":"4"}},{"id":979808,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-05T22:46:32.000Z","date":"2025-12-02","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":9.0059,"value":9005.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $8.89 to $9.06. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":1266,"source":{"system":"sec-edgar","filing":"0001841785-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34956/000184178525000003/primary_doc.xml","form_type":"4"}},{"id":1141601,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-20T22:54:40.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":625000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on May 16, 2026, and thereafter 1/36th of the remaining shares will vest on the last\nday of each following month for a period of 36 months, subject to the Reporting Person's continued employment."}],"balance_after":625000,"derivative":{"exercise_price":5.89,"expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0001654954-25-005950","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495425005950/section16.xml","form_type":"4"}},{"id":1334921,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-13T01:09:56.000Z","date":"2024-12-10","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":500000,"derivative":{"exercise_price":5.94,"exercise_date":"2025-12-10","expiration_date":"2034-12-10","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001654954-24-015477","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495424015477/section16.xml","form_type":"4"}},{"id":1508282,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-21T21:01:41.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest and become exercisable as follows:  25% of the underlying shares of common stock vest and become exercisable on each of May 17, 2025, May 17, 2026, May 17, 2027 and May 17, 2028, subject to the Reporting Person's continued employment."}],"balance_after":119,"derivative":{"exercise_price":3.549,"expiration_date":"2034-05-17","underlying":"Common Stock","underlying_shares":119},"source":{"system":"sec-edgar","filing":"0001654954-24-006745","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495424006745/section16.xml","form_type":"4"}},{"id":2152433,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-09-23T20:32:55.000Z","date":"2022-09-21","kind":"gift","acquired":true,"shares":1909585,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Stuart Rich 2022 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift of Issuer's common stock to the Stuart Rich 2022 Irrevocable Trust. a Spousal Lifetime Access Trust (the \"Trust\"), for the benefit of Reporting Person's spouse and their children."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is special asset advisor to the Trust. As such, the Reporting Person has voting and dispositive power over the reported securities held in the Trust, however disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":1909585,"source":{"system":"sec-edgar","filing":"0001654954-22-012922","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495422012922/section16.xml","form_type":"4"}},{"id":2152432,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-09-23T20:32:55.000Z","date":"2022-09-21","kind":"gift","acquired":false,"shares":1909585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift of Issuer's common stock to the Stuart Rich 2022 Irrevocable Trust. a Spousal Lifetime Access Trust (the \"Trust\"), for the benefit of Reporting Person's spouse and their children."}],"balance_after":424347,"source":{"system":"sec-edgar","filing":"0001654954-22-012922","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495422012922/section16.xml","form_type":"4"}},{"id":2237061,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-11T01:34:36.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable as follows: options with respect to 25,000 underlying shares of Common Stock vest and become exercisable on each of June 9, 2023, June 9, 2024, June 9, 2025, and June 9, 2026, subject to the Reporting Person's continued employment."}],"balance_after":100000,"derivative":{"exercise_price":0.62,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001654954-22-008239","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495422008239/section16.xml","form_type":"4"}},{"id":2484650,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-06T22:08:55.000Z","date":"2021-11-29","kind":"gift","acquired":true,"shares":1909585,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Andrea Rich 2021 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift of Issuer's common stock to the Andrea Rich 2021 Irrevocable Trust, a Spousal Lifetime Access Trust (the \"Trust\"), for the benefit of the Reporting Person and the Reporting Person's children."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is co-trustee of the Trust and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":1909585,"source":{"system":"sec-edgar","filing":"0001654954-21-012861","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495421012861/section16.xml","form_type":"4"}},{"id":2484649,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2021-12-06T22:08:55.000Z","date":"2021-11-29","kind":"gift","acquired":false,"shares":1909585,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift of Issuer's common stock to the Andrea Rich 2021 Irrevocable Trust, a Spousal Lifetime Access Trust (the \"Trust\"), for the benefit of the Reporting Person and the Reporting Person's children."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001654954-21-012861","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495421012861/section16.xml","form_type":"4"}},{"id":2484648,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2021-12-06T22:08:55.000Z","date":"2021-10-12","kind":"gift","acquired":true,"shares":1909585,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":1909585,"source":{"system":"sec-edgar","filing":"0001654954-21-012861","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495421012861/section16.xml","form_type":"4"}},{"id":2484647,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-06T22:08:55.000Z","date":"2021-10-12","kind":"gift","acquired":false,"shares":1909585,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2333932,"source":{"system":"sec-edgar","filing":"0001654954-21-012861","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495421012861/section16.xml","form_type":"4"}},{"id":2669473,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Medical Officer"}}],"security":"Series B Preferred Stock","published_at":"2021-06-15T20:34:40.000Z","date":"2021-06-11","kind":"exercise","acquired":false,"shares":3581,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"As described further in Note 1, above, the disposition of the Series B Preferred Stock and the acquisition of Common Stock occurred pursuant to an automatic conversion; as such, no consideration was paid to or payable by the Reporting Person pursuant to this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"As described further in Note 1, above, the disposition of the Series B Preferred Stock and the acquisition of Common Stock occurred pursuant to an automatic conversion; as such, no consideration was paid to or payable by the Reporting Person pursuant to this transaction."}],"balance_after":0,"derivative":{"exercise_date":"2021-06-11","expiration_date":"2021-06-11","underlying":"Common Stock","underlying_shares":3581000},"source":{"system":"sec-edgar","filing":"0001654954-21-006927","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495421006927/section16.xml","form_type":"4"}},{"id":2669472,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-15T20:34:40.000Z","date":"2021-06-11","kind":"exercise","acquired":true,"shares":3581000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 10, 2021, the shareholders of Tenax Therapeutics, Inc. voted in favor of the conversion of all Series B Preferred Stock to Common Stock. Pursuant to this action, all Series B Preferred Stock owned by the Reporting Person converted automatically to shares of Common Stock on June 11, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"As described further in Note 1, above, the disposition of the Series B Preferred Stock and the acquisition of Common Stock occurred pursuant to an automatic conversion; as such, no consideration was paid to or payable by the Reporting Person pursuant to this transaction."}],"balance_after":4243517,"source":{"system":"sec-edgar","filing":"0001654954-21-006927","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495421006927/section16.xml","form_type":"4"}},{"id":2894564,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-27T21:33:18.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in four equal installments, with 25% vesting after the start of a Phase 3 clinical trial, 25% vesting after the database lock with respect to the trial, 25% vesting after the opening of an Investigational New Drug Application with the U.S. Food and Drug Administration (\"FDA\"), and 25% vesting after the approval from the FDA."}],"balance_after":250000,"derivative":{"exercise_price":1.78,"expiration_date":"2031-01-15","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001654954-21-000839","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495421000839/section16.xml","form_type":"4"}},{"id":2894563,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Series B Preferred Stock","published_at":"2021-01-27T21:33:18.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":3581,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired the securities in connection with the merger of PHPrecisionMed Inc. with and into a wholly owned subsidiary of Tenax Therapeutics, Inc. (the \"Transaction\")."}],"balance_after":3581,"source":{"system":"sec-edgar","filing":"0001654954-21-000839","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495421000839/section16.xml","form_type":"4"}},{"id":2894562,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69478,"kind":"person","name":"Rich Stuart","position":1,"cik":"0001841785","reported_name":"Rich Stuart","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-27T21:33:18.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":662517,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired the securities in connection with the merger of PHPrecisionMed Inc. with and into a wholly owned subsidiary of Tenax Therapeutics, Inc. (the \"Transaction\")."}],"balance_after":662517,"source":{"system":"sec-edgar","filing":"0001654954-21-000839","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495421000839/section16.xml","form_type":"4"}}]}